Advantages of insulin pump therapy: Letter: Original Observation

Diabetic Medicine

Volumn 26, Issue 12, 2009, Pages 1306-

  Partridge, H ^a   Kerr, D ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

DRUG ADMINISTRATION ROUTE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; LETTER; PRACTICE GUIDELINE; UNITED KINGDOM;

DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 70549113764     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02833.x     Document Type: Letter

References (2)

1. Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in Type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabet Med 2008 25 : 765 774.
2. NICE. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57). London : National Institute for Health and Clinical Excellence, 2008.